Researchers analyzed more than 50,000 claims records to compare MACE risk when patients with diabetes started tirzepatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results